What is the appropriate evaluation and treatment for a patient presenting with a resting heart rate >100 bpm?

Evaluation and Management of High Resting Heart Rate (>100 bpm)

The first priority is to obtain a 12-lead ECG immediately to distinguish between physiological sinus tachycardia and pathological supraventricular tachycardia (SVT), as this fundamentally determines your management approach 1, 2.

Initial Diagnostic Approach

Immediate ECG Assessment

When you see a heart rate >100 bpm, the ECG will guide everything:

• If QRS <120 ms and regular rhythm: You're dealing with either physiological sinus tachycardia or SVT (AVNRT, atrial flutter, atrial tachycardia)
• If irregular rhythm: Consider atrial fibrillation, multifocal atrial tachycardia (MAT), or atrial flutter with variable block
• If QRS ≥120 ms: Apply Brugada criteria to distinguish ventricular tachycardia from SVT with aberrancy 1

Critical History Elements

Don't just take a "comprehensive history"—specifically ask about:

• Onset pattern: Sudden (suggests SVT) vs. gradual (suggests sinus tachycardia)
• Triggers: Exertion, caffeine, alcohol, emotional stress
• Associated symptoms: Palpitations, chest pain, dyspnea, syncope, neck pulsations
• Secondary causes: Fever, infection, dehydration, anemia, hyperthyroidism, pain
• Substances: Albuterol, salmeterol, amphetamines, cocaine, excessive caffeine 1
• Cardiac history: Prior arrhythmias, structural heart disease, family history of sudden death

Management Algorithm

For Physiological Sinus Tachycardia

Treat the underlying cause—the tachycardia itself is not the disease 1. Systematically exclude:

1. Hyperthyroidism (check TSH)
2. Anemia (check CBC)
3. Dehydration (assess volume status, electrolytes)
4. Infection/fever (clinical assessment, inflammatory markers)
5. Heart failure (BNP, echocardiography if indicated)
6. Exogenous substances (medication review, drug screen if appropriate)

The tachycardia should resolve once you correct the underlying pathology 1.

For Inappropriate Sinus Tachycardia (IST)

If you've excluded all secondary causes and the patient has:

• Resting heart rate >100 bpm
• Average 24-hour heart rate >90 bpm
• Debilitating symptoms (weakness, fatigue, lightheadedness, palpitations)

This is IST, and the prognosis is benign—treatment is purely for symptom reduction and may not be necessary 1.

When treatment is warranted for symptoms:

• Beta-blockers (bisoprolol 5 mg twice daily) or ivabradine (5 mg twice daily) are equally effective and safe 3
• Both reduce resting heart rate from ~102 bpm to 74-78 bpm
• Both significantly improve quality of life (EHRA symptom scores)
• Avoid beta-blockers if: Severe bronchospastic disease, acute decompensated heart failure, severe conduction abnormalities, or sinus node dysfunction 4

For Acute SVT (AVNRT, AVRT, Atrial Tachycardia)

If the patient is hemodynamically stable with regular narrow-complex tachycardia:

1. First-line: Vagal maneuvers (Class I recommendation) 4

   • Valsalva maneuver: Bear down against closed glottis for 10-30 seconds (≥30-40 mmHg pressure)
   • Carotid massage: 5-10 seconds after confirming no bruit
   • Ice-cold wet towel to face
   • Success rate ~28% when switching between techniques

2. Second-line: IV adenosine (Class I recommendation) 4

   • Both therapeutic and diagnostic
   • Terminates AVNRT in majority of cases

3. Third-line: IV beta-blockers, diltiazem, or verapamil (Class IIa) 4

   • Avoid verapamil/diltiazem if: Severe conduction abnormalities or sinus node dysfunction 4

4. If medications fail: Synchronized cardioversion (Class I) 1

If the patient is hemodynamically unstable: Proceed directly to synchronized cardioversion 1.

Common Pitfalls

• Don't assume all tachycardia >100 bpm is pathological: Physiological sinus tachycardia is appropriate in many contexts (exercise, anxiety, pain, fever)
• Don't treat IST aggressively: The prognosis is benign; only treat if symptoms are debilitating 1
• Don't use verapamil in MAT with severe pulmonary disease: It can exacerbate bronchospasm, though metoprolol has been used successfully after correcting hypoxia 4
• Don't forget 24-hour Holter monitoring: This is the mainstay for documenting the arrhythmia if not captured on initial ECG 2
• Don't overlook structural heart disease: Echocardiography is appropriate when evaluating palpitations to exclude cardiomyopathy 2

Prognostic Considerations

Resting heart rate >60 bpm shows continuous increase in cardiovascular risk 5. While defining an optimal heart rate for individuals is difficult, maintaining resting heart rate substantially below 90-100 bpm is desirable for long-term cardiovascular outcomes 5. However, this applies to chronic management, not acute presentations where identifying and treating the underlying cause takes precedence.